Data / Form D filings / Mytide Therapeutics, Inc.
Mytide Therapeutics, Inc.: Form D filings
Mytide Therapeutics, Inc., a biotechnology company in Boston, MA, filed 3 Form D notices with the SEC between 2022 and 2023. The latest, on January 6, 2023, reports $1.2 million sold of a $2.5 million offering to 9 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 451 D STREET SUITE 707, Boston, MA, 02210
- Phone
- (207) 659-4206
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1905245
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 6, 2023 | New notice | $2,500,000 | $1,164,111 | $1,335,889 | 9 | Dec 23, 2022 | sec.gov |
| Jun 7, 2022 | Amendment | $7,067,713 | $7,067,713 | 23 | Dec 30, 2021 | sec.gov | |
| Jan 21, 2022 | New notice | $7,067,713 | $6,567,713 | $500,000 | 15 | Dec 30, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Errik Anderson | Director | |
| Jason Norris | Executive Officer, Director, Promoter | |
| Dale Thomas | Executive Officer, Director, Promoter |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Jan 2, 2023 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Mytide Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.